- Home
- TGB vs OPCH Comparison
TGB vs OPCH Comparison
Compare TGB & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.44
HOLD
Current Price
$23.57
Company Overview
Basic Information| Metric | TGB | OPCH |
|---|---|---|
| Founded | 1966 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2002 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TGB | OPCH |
|---|---|---|
| Price | $8.44 | $23.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $9.50 | ★ $36.57 |
| AVG Volume (30 Days) | ★ 5.4M | 1.9M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | $71.94 | $7.21 |
| Revenue Next Year | $26.53 | $8.55 |
| P/E Ratio | ★ N/A | $80.86 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $3.28 | $18.01 |
| 52 Week High | $9.82 | $36.80 |
Technical Indicators
Market Signals| Indicator | TGB | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 52.95 |
| Support Level | $8.22 | $22.97 |
| Resistance Level | $9.08 | $24.83 |
| Average True Range (ATR) | 0.41 | 0.52 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 18.44 | 47.10 |
Price Performance
Historical Comparison TGB
OPCH
About TGB Taseko Mines Ltd.
Trekor Metals Ltd is a North American copper producer with a development pipeline of minerals projects and properties in Canada and the United States. The company's properties include Gibraltar Mine, Florence Copper, Yellowhead Project, Aley Project, and New Prosperity.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.